In this video, Dr. McFarland of Memorial Sloan-Kettering Cancer Center spoke with Cancer Network at ASCO 2019 about depression in lung cancer and dopamine as potential therapy.
Cancer Network spoke with Daniel C. McFarland, DO, medical oncologist at Memorial Sloan-Kettering Cancer Center, at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the relationship between inflammation and depression in lung cancer patients and the potential efficacy of dopamine in treating depression.
Eric Ko on Combining Radiation Therapy With Immunotherapy to Treat Non–Small-Cell Lung Cancer
September 18th 2018ONCOLOGY spoke with Eric Ko, MD, PhD, who recently published a review article with his colleagues on strategies for combining radiation therapy with immunotherapy for the treatment of non–small-cell lung cancer.